CRXM's free cash flow for Q was $-337.87K. For the fiscal year, CRXM's free cash flow was decreased by $-999.28K and operating cash flow was $-337.87K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Operating Cash Flow	$ -1.13M	$ -1.13M	$ -137.16K	$ -451.50K	$ -1.06M	$ -2.02M
Investing Cash Flow	$ -4.00	$ -3.43K	-	$ 650.00K	-	$ -171.73K
Financing Cash Flow	$ 1.52M	$ 1.52M	$ 55.45K	$ -165.37K	$ 180.98K	$ 3.10M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 2.48M	$ 386.03K	$ 400.00	$ 82.11K	$ 48.99K	$ 930.40K
Income Tax Paid Supplemental Data	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Interest Paid Supplemental Data	$ 12.42K	$ 12.42K	$ 8.72K	$ 10.27K	$ 8.58K	$ 21.07K
Issuance Of Capital Stock	-	$ 1.70M	-	-	-	$ 3.00M
Issuance Of Debt	$ 193.48K	$ 193.48K	$ 155.21K	$ 29.25K	$ 211.50K	$ 104.19K
Repayment Of Debt	$ -35.38K	$ -204.53K	$ -99.76K	$ -194.62K	$ -30.52K	-
Free Cash Flow	$ -1.14M	$ -1.14M	$ -137.16K	$ -451.50K	$ -1.06M	$ -2.20M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Taxus Cardium Pharmaceuticals Group Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing